Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study.
Markar SR, Noordman BJ, Mackenzie H, Findlay JM, Boshier PR, Ni M, Steyerberg EW, van der Gaast A, Hulshof MCCM, Maynard N, van Berge Henegouwen MI, Wijnhoven BPL, Reynolds JV, Van Lanschot JJB, Hanna GB. Markar SR, et al. Among authors: van der gaast a, van berge henegouwen mi, van lanschot jjb. Ann Oncol. 2017 Mar 1;28(3):519-527. doi: 10.1093/annonc/mdw560. Ann Oncol. 2017. PMID: 28039180 Free PMC article. Clinical Trial.
Induction chemotherapy followed by surgery for advanced oesophageal cancer.
Toxopeus EL, Talman S, van der Gaast A, Spaander VM, van Rij CM, Krak NC, Biermann K, Tilanus HW, Mathijssen RH, van Lanschot JJ, Wijnhoven BP. Toxopeus EL, et al. Among authors: van lanschot jj, van rij cm, van der gaast a. Eur J Surg Oncol. 2015 Mar;41(3):323-32. doi: 10.1016/j.ejso.2014.11.043. Epub 2014 Dec 3. Eur J Surg Oncol. 2015. PMID: 25534280
Prediction of survival in patients with oesophageal or junctional cancer receiving neoadjuvant chemoradiotherapy and surgery.
Shapiro J, van Klaveren D, Lagarde SM, Toxopeus EL, van der Gaast A, Hulshof MC, Wijnhoven BP, van Berge Henegouwen MI, Steyerberg EW, van Lanschot JJ. Shapiro J, et al. Among authors: van klaveren d, van lanschot jj, van der gaast a, van berge henegouwen mi. Br J Surg. 2016 Jul;103(8):1039-47. doi: 10.1002/bjs.10142. Epub 2016 Apr 26. Br J Surg. 2016. PMID: 27115731
Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
Noordman BJ, Verdam MGE, Lagarde SM, Shapiro J, Hulshof MCCM, van Berge Henegouwen MI, Wijnhoven BPL, Nieuwenhuijzen GAP, Bonenkamp JJ, Cuesta MA, Plukker JTM, Spillenaar Bilgen EJ, Steyerberg EW, van der Gaast A, Sprangers MAG, van Lanschot JJB; CROSS Study Group. Noordman BJ, et al. Among authors: van berge henegouwen mi, van der gaast a, van lanschot jjb. Ann Oncol. 2018 Feb 1;29(2):445-451. doi: 10.1093/annonc/mdx726. Ann Oncol. 2018. PMID: 29126244 Free article. Clinical Trial.
Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer.
Noordman BJ, Verdam MGE, Onstenk B, Heisterkamp J, Jansen WJBM, Martijnse IS, Lagarde SM, Wijnhoven BPL, Acosta CMM, van der Gaast A, Sprangers MAG, van Lanschot JJB. Noordman BJ, et al. Among authors: van der gaast a, van lanschot jjb. Ann Surg Oncol. 2019 Dec;26(13):4765-4772. doi: 10.1245/s10434-019-07779-w. Epub 2019 Oct 16. Ann Surg Oncol. 2019. PMID: 31620943 Free PMC article.
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS).
van Heijl M, van Lanschot JJ, Koppert LB, van Berge Henegouwen MI, Muller K, Steyerberg EW, van Dekken H, Wijnhoven BP, Tilanus HW, Richel DJ, Busch OR, Bartelsman JF, Koning CC, Offerhaus GJ, van der Gaast A. van Heijl M, et al. Among authors: van lanschot jj, van dekken h, van berge henegouwen mi, van der gaast a. BMC Surg. 2008 Nov 26;8:21. doi: 10.1186/1471-2482-8-21. BMC Surg. 2008. PMID: 19036143 Free PMC article. Clinical Trial.
Preoperative chemoradiotherapy for esophageal or junctional cancer.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A; CROSS Group. van Hagen P, et al. Among authors: van lanschot jj, van dekken h, van rij cm, van berge henegouwen mi, van der gaast a, van der sangen mj. N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088. N Engl J Med. 2012. PMID: 22646630 Free article. Clinical Trial.
Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial.
Noordman BJ, Wijnhoven BPL, Lagarde SM, Boonstra JJ, Coene PPLO, Dekker JWT, Doukas M, van der Gaast A, Heisterkamp J, Kouwenhoven EA, Nieuwenhuijzen GAP, Pierie JEN, Rosman C, van Sandick JW, van der Sangen MJC, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Lanschot JJB; SANO-study group. Noordman BJ, et al. Among authors: van der sangen mjc, van sandick jw, van der zaag es, van der gaast a, van lanschot jjb. BMC Cancer. 2018 Feb 6;18(1):142. doi: 10.1186/s12885-018-4034-1. BMC Cancer. 2018. PMID: 29409469 Free PMC article.
136 results